ASO Author Reflections: What are the Prognostic Factors for Achieving Long-Term Survival in MPM Patients Treated with CRS+HIPEC? Does the Conditional Survival Analysis Provide Special Information?

Xin-Li Liang^{1

2}, Yan Li^{3

4}

Affiliations

¹ Department of Surgical Oncology, Beijing Tsinghua Changgung Hospital, Tsinghua University, Beijing, China.
² Department of Peritoneal Cancer Surgery, Beijing Shijitan Hospital, Capital Medical University, Beijing, China.
³ Department of Surgical Oncology, Beijing Tsinghua Changgung Hospital, Tsinghua University, Beijing, China. liyansd2@163.com.
⁴ Department of Peritoneal Cancer Surgery, Beijing Shijitan Hospital, Capital Medical University, Beijing, China. liyansd2@163.com.

Xin-Li Liang et al. Ann Surg Oncol. 2025 Apr.

. 2025 Apr;32(4):2936-2937.

doi: 10.1245/s10434-024-16681-z. Epub 2024 Dec 7.

Xin-Li Liang^{1

2}, Yan Li^{3

4}

¹ Department of Surgical Oncology, Beijing Tsinghua Changgung Hospital, Tsinghua University, Beijing, China.
² Department of Peritoneal Cancer Surgery, Beijing Shijitan Hospital, Capital Medical University, Beijing, China.
³ Department of Surgical Oncology, Beijing Tsinghua Changgung Hospital, Tsinghua University, Beijing, China. liyansd2@163.com.
⁴ Department of Peritoneal Cancer Surgery, Beijing Shijitan Hospital, Capital Medical University, Beijing, China. liyansd2@163.com.

No abstract available

References

1. Turner K, Varghese S, Alexander HR Jr. Current concepts in the evaluation and treatment of patients with diffuse malignant peritoneal mesothelioma. J Natl Compr Canc Netw. 2012;10(1):49–57. - DOI - PubMed
1. Alexander HR Jr, Bartlett DL, Pingpank JF, et al. Treatment factors associated with long-term survival after cytoreductive surgery and regional chemotherapy for patients with malignant peritoneal mesothelioma. Surgery. 2013;153(6):779–86. - DOI - PubMed
1. Han L, Dai W, Mo S, et al. Nomogram of conditional survival probability of long-term survival for metastatic colorectal cancer: a real-world data retrospective cohort study from SEER database. Int J Surg. 2021;92:106013. - DOI - PubMed
1. Beal EW, Srinivas S, Shen C, et al. Conditional survival following cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for peritoneal surface malignancies: an analysis from the US HIPEC collaborative. Ann Surg Oncol. 2023;30(3):1840–9. - DOI - PubMed
1. Liang XL, Su YD, Li XB, et al. Prognostic factors of long-term survival and conditional survival analysis in MPM patients treated with CRS+HIPEC: a retrospective study of two centers. Ann Surg Oncol. 2024. https://doi.org/10.1245/s10434-024-16485-1 . - DOI - PubMed - PMC